Healthcare business opportunities are global. Sadly, as COVID has made all too apparent, risks can be global too. Next week, HBI has arranged an all-star virtual line-up to discuss the state of the regions, a three day event covering everywhere from CEE to China.
China remains the big enigma in healthcare services. Mass scale innovation is building giants like Ping An, but it’s a tough market for western investors to crack, and few have succeeded. On Wednesday next week, we talk to the people who know how to do it.
There’s also a deep dive into DACH – by far Europe’s largest market offering huge scope for consolidation – before a step east into Russia where there’s a lot to learn from fast-growth outpatient models. Is the growth worth the risk? A look at LATAM including its huge payor/provider models rounds off the day.
Our second day takes a similar deep delve into SE Asia, the Nordics and Mena. Asia has some of the fastest-growing lab and outpatient groups in the world. What can we learn from this? Meanwhile the Nordic region has advanced private/public cooperation that deserves study, and leads the way in digital and value health.
Our final day finds us in South Asia (India, Pakistan and Bangladesh) and its fast-growing markets are showing some meteoric growth. CEE is also in the spotlight – replete with opportunities, but how far does popularism impact on this and will it remain buoyant? We end the day with a look at Africa. Vast in scale and large in opportunity, how far is the promise of leapfrogging over older healthcare models holding true – and which are the countries to watch.
If you’d like to hear more about this event, where speaker companies include Aleris, Amedes, Bupa, Fullerton, IFC, L.E.K. Consulting, McKinsey & Company, McDermott Will & Emery, Medicover, MediGroup, True North, Sistema, CLICK HERE.We would welcome your thoughts on this story. Email your views to David Farbrother or call 0207 183 3779.